SCM
JAZZ icon

Stevens Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Stevens Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-6,568
Closed -$980K – 219
2019
Q4 		$980K Buy
6,568
+556
+9% +$75.7K 0.09% 230
2019
Q3 		$770K Buy
+6,012
New +$806K 0.07% 277
2019
Q2 		– Sell
-28,569
Closed -$4.08M – 740
2019
Q1 		$4.08M Buy
+28,569
New +$3.73M 0.17% 161
2018
Q4 		– Sell
-13,557
Closed -$2.28M – 803
2018
Q3 		$2.28M Buy
+13,557
New +$2.33M 0.08% 278
2018
Q1 		– Sell
-37,805
Closed -$5.09M – 861
2017
Q4 		$5.09M Buy
37,805
+36,126
+2,152% +$5.01M 0.2% 158
2017
Q3 		$246K Sell
1,679
-1,386
-45% -$210K 0.01% 713
2017
Q2 		$477K Buy
+3,065
New +$469K 0.02% 584
2017
Q1 		– Sell
-52,291
Closed -$5.7M – 980
2016
Q4 		$5.7M Buy
52,291
+30,900
+144% +$3.44M 0.23% 123
2016
Q3 		$2.6M Buy
21,391
+2,018
+10% +$272K 0.11% 236
2016
Q2 		$2.74M Buy
+19,373
New +$2.86M 0.11% 233
2016
Q1 		– Sell
-12,571
Closed -$1.77M – 1002
2015
Q4 		$1.77M Sell
12,571
-8,788
-41% -$1.22M 0.07% 313
2015
Q3 		$2.84M Buy
21,359
+10,265
+93% +$1.77M 0.13% 178
2015
Q2 		$1.95M Buy
11,094
+2,173
+24% +$390K 0.07% 286
2015
Q1 		$1.54M Sell
8,921
-6,823
-43% -$1.17M 0.05% 326
2014
Q4 		$2.58M Buy
+15,744
New +$2.61M 0.09% 253
2014
Q2 		– Sell
-3,560
Closed -$494K – 1181
2014
Q1 		$494K Sell
3,560
-2,152
-38% -$324K 0.01% 665
2013
Q4 		$723K Sell
5,712
-10,063
-64% -$1.04M 0.02% 547
2013
Q3 		$1.45M Buy
+15,775
New +$1.27M 0.04% 407

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Stevens Capital Management's JAZZ Position: Q1 2020 in Review

Stevens Capital Management sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2020, closing a stake of 6,568 shares — an estimated $980K sold.

Stevens Capital Management first reported a position in JAZZ in Q3 2013 and held it in 18 quarters. The position peaked at $5.7M in Q4 2016. 407 funds tracked by Wall St. Rank hold JAZZ as of Q1 2020.

  • Stevens Capital Management reported no remaining Jazz Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Stevens Capital Management sold 6,568 Jazz Pharmaceuticals shares in Q1 2020, an estimated $980K.
  • Stevens Capital Management first reported a position in Jazz Pharmaceuticals in Q3 2013 and held it in 18 quarters.
  • Stevens Capital Management's Jazz Pharmaceuticals position peaked at $5.7M in Q4 2016.
  • 407 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2020.

Based on Stevens Capital Management's 13F filing for Q1 2020, filed 21 Apr 2020.